2Seventy Bio Inc
NASDAQ:TSVT

Watchlist Manager
2Seventy Bio Inc Logo
2Seventy Bio Inc
NASDAQ:TSVT
Watchlist
Price: 3.05 USD -0.33% Market Closed
Market Cap: 157.3m USD
Have any thoughts about
2Seventy Bio Inc?
Write Note

EV/EBIT
Enterprise Value to EBIT

0.3
Current
-0.6
Median
4
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
0.3
=
Enterprise Value
-35.3m USD
/
EBIT
-138.7m USD
All Countries
Close
EBIT Growth EV/EBIT to Growth
US
2Seventy Bio Inc
NASDAQ:TSVT
Average EV/EBIT: 18.5
0.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 130 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
24%
1
US
Amgen Inc
NASDAQ:AMGN
30.3
24%
1.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.3
10%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.8
13%
1.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.7 N/A N/A
AU
CSL Ltd
ASX:CSL
24.8
16%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
12%
1.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -80.2 N/A N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
0.3
2-Years Forward
EV/EBIT
1.4
3-Years Forward
EV/EBIT
9

See Also

Discover More